{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:14:10Z","timestamp":1792088050606,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.anai.2009.11.020","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T05:20:33Z","timestamp":1264569633000},"page":"13-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class"],"prefix":"10.1016","volume":"104","author":[{"given":"Michael","family":"Benninger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith R.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Blaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Chipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berrylin","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Krouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Marple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Storms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kaliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2009.11.020_bib1","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.otohns.2007.02.031","article-title":"Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction","volume":"136","author":"Marple","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anai.2009.11.020_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib3","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ACI.0b013e3282f3f42f","article-title":"The voice of the patients: allergic rhinitis is not a trivial disease","volume":"8","author":"Valovirta","year":"2007","journal-title":"Curr Opin Allergy Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/09031936.00032007","article-title":"The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring","volume":"30","author":"Kohler","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.anai.2009.11.020_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jaci.2005.09.047","article-title":"Severity and impairment of allergic rhinitis in patients consulting in primary care","volume":"117","author":"Bousquet","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1185\/030079906X112552","article-title":"Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective","volume":"22","author":"Lamb","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anai.2009.11.020_bib9","first-page":"49","article-title":"Presenteeism: at work\u2014but out of it","author":"Hemp","year":"2004","journal-title":"Harvard Business Review"},{"key":"10.1016\/j.anai.2009.11.020_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60560-1","article-title":"A novel and effective approach to treating rhinitis with nasal antihistamines","volume":"99","author":"Kaliner","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1081-1206(10)60452-8","article-title":"Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis","volume":"100","author":"Anolik","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1081-1206(10)61894-7","article-title":"A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis","volume":"88","author":"Bende","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1081-1206(10)60804-6","article-title":"Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis","volume":"97","author":"Berger","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62086-8","article-title":"Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion","volume":"89","author":"Berger","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1081-1206(10)62179-5","article-title":"Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine","volume":"91","author":"Berger","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0091-6749(96)80151-5","article-title":"Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis","volume":"97","author":"Bernstein","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1081-1206(10)63041-4","article-title":"Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis","volume":"79","author":"Bernstein","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1398-9995.1985.tb04156.x","article-title":"Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate","volume":"40","author":"Bjerrum","year":"1985","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1081-1206(10)63084-0","article-title":"Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis","volume":"79","author":"Bronsky","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2500\/108854198778604112","article-title":"Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies","volume":"19","author":"Bronsky","year":"1998","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2009.11.020_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-3038.2005.00351.x","article-title":"Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2\u20136yr","volume":"17","author":"Chen","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1081-1206(10)61098-8","article-title":"Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis","volume":"97","author":"Ciebada","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib23","first-page":"391","article-title":"Efficacy and safety of desloratadine\/pseudoephedrine tablet, 2.5\/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis","volume":"26","author":"Chervinsky","year":"2005","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2009.11.020_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-3038.2005.00216.x","article-title":"Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial","volume":"16","author":"deBlic","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/j.1398-9995.1997.tb01027.x","article-title":"Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis","volume":"52","author":"Gehanno","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib26","first-page":"56","article-title":"A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis","volume":"14","author":"Hampel","year":"2004","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2500\/aap.2006.27.2862","article-title":"Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCL nasal spray 0.6% compared with vehicle placebo","volume":"27","author":"Hampel","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2009.11.020_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1081-1206(10)61682-1","article-title":"Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis","volume":"91","author":"Hampel","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0091-6749(99)70070-9","article-title":"Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis","volume":"104","author":"Howarth","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2007.02.022","article-title":"Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis","volume":"119","author":"Kaiser","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0091-6749(77)90049-5","article-title":"Clinical evaluation of intranasal topical flunisolide therapy in allergic rhinitis","volume":"59","author":"Kammermeyer","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1081-1206(10)60914-3","article-title":"Desloratadine therapy for symptoms associated with perennial allergic rhinitis","volume":"96","author":"Kim","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1081-1206(10)61468-8","article-title":"Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine","volume":"93","author":"LaForce","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1081-1206(10)60663-1","article-title":"Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily","volume":"99","author":"Lumry","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1081-1206(10)61349-X","article-title":"Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms","volume":"96","author":"Martin","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1081-1206(10)61025-3","article-title":"Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis","volume":"95","author":"Meltzer","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib37","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mai.2000.106040","article-title":"Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial","volume":"105","author":"Meltzer","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0091-6749(88)90018-8","article-title":"Efficacy of azelastine in perennial allergic rhinitis: clinical and rhinomanometric evaluation","volume":"82","author":"Meltzer","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib39","first-page":"391","article-title":"Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity and activity impairment","volume":"23","author":"Murray","year":"2002","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2009.11.020_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1081-1206(10)62991-2","article-title":"Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis","volume":"80","author":"Murris-Espin","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1081-1206(10)60477-2","article-title":"Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis","volume":"100","author":"Nathan","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1081-1206(10)61891-1","article-title":"Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall","volume":"88","author":"Nayak","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2222.2003.01596.x","article-title":"The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial","volume":"33","author":"Noonan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib44","first-page":"436","article-title":"Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action","volume":"61","author":"Oei","year":"1988","journal-title":"Ann Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1081-1206(10)60986-6","article-title":"Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs. the individual components in the treatment of seasonal allergic rhinitis","volume":"94","author":"Pleskow","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1081-1206(10)61208-2","article-title":"Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial","volume":"95","author":"Potter","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1398-9995.2003.00171.x","article-title":"Levocetirizine is effective for symptoms relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites","volume":"58","author":"Potter","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)61174-X","article-title":"Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar","volume":"95","author":"Ratner","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1081-1206(10)61847-9","article-title":"Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast","volume":"90","author":"Ratner","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1081-1206(10)60968-4","article-title":"Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14- year-old children with seasonal allergic rhinitis","volume":"97","author":"Razi","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mai.2003.168","article-title":"Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis","volume":"111","author":"Simons","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib52","first-page":"300","article-title":"Multicenter, double-blind, placebo-controlled trial of triamcinolone acetonide nasal aerosol in the treatment of perennial allergic rhinitis","volume":"64","author":"Spector","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib53","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0091-6749(89)90450-8","article-title":"SCH 434: a new antihistamine\/decongestant for seasonal allergic rhinitis","volume":"83","author":"Storms","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib54","first-page":"145","article-title":"Flunisolide nasal spray for the treatment of children with seasonal allergic rhinitis","volume":"41","author":"Strem","year":"1978","journal-title":"Ann Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0091-6749(99)70120-X","article-title":"The efficacy and safety of fexofenadine HCL and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis","volume":"104","author":"Sussman","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archotol.1979.00790230019004","article-title":"Flunisolide intranasal spray in the treatment of perennial rhinitis","volume":"105","author":"Sy","year":"1979","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.anai.2009.11.020_bib57","first-page":"234","article-title":"Multicenter evaluation of triamcinolone acetonide nasal aerosol in the treatment of adult patients with seasonal allergic rhinitis","volume":"64","author":"Tinkelman","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib58","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1046\/j.1398-9995.2003.00261.x","article-title":"Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period","volume":"58","author":"Van Adelsberg","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib59","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mai.2003.1384","article-title":"Fexofenadine is efficacious and safe in children (aged 6\u201311 years) with seasonal allergic rhinitis","volume":"111","author":"Wahn","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1398-9995.1982.tb02320.x","article-title":"Evaluation of flunisolide nasal solution in the symptomatic treatment of perennial rhinitis","volume":"37","author":"Warland","year":"1982","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib61","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2222.2001.01088.x","article-title":"A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma","volume":"31","author":"Wilson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib62","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1046\/j.1365-2745.2002.01509.x","article-title":"Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis","volume":"32","author":"Wilson","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.0022-0477.2001.01252.x","article-title":"A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis","volume":"32","author":"Wilson","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib64","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2222.2001.00964.x","article-title":"Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis","volume":"31","author":"Wilson","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2009.11.020_bib65","first-page":"1","article-title":"Topical nasal steroids for intermittent and persistent allergic rhinitis in children","volume":"1","author":"Al Sayyad","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anai.2009.11.020_bib66","series-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.6","year":"2006"},{"key":"10.1016\/j.anai.2009.11.020_bib67","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11882-004-0009-1","article-title":"Evidence-based strategies for treatment of allergic rhinitis","volume":"4","author":"Portnoy","year":"2004","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2009.11.020_bib68","first-page":"89","article-title":"Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines","volume":"4","author":"Stempel","year":"1998","journal-title":"Am J Man Care"},{"key":"10.1016\/j.anai.2009.11.020_bib69","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bmj.317.7173.1624","article-title":"Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials","volume":"317","author":"Weiner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.anai.2009.11.020_bib70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1081-1206(10)62085-6","article-title":"Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis","volume":"89","author":"Yanez","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2009.11.020_bib71","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1081-1206(10)60408-5","article-title":"Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis","volume":"100","author":"Ratner","year":"2008","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120609000210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120609000210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:37:27Z","timestamp":1761050247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120609000210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1081120609000210"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2009.11.020","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2009.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}